← Leaderboards
Emily Kate Acton
University Of Pennsylvania
$71,008
Attributed
$71,008
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2023–24$50K$37.5K$25K$12.5K$0
'23
'24
Funding mix
By agency
NIH$71,008 · 1
By mechanism
F31$71,008 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Scott L Diamond$29,536,327
- Trevor M. Penning$29,812,455
- Meera Vedavalli Sundaram$13,421,752
- Narayan G Avadhani$16,577,650
- Ruth J Muschel$6,216,603
Others in their field
Other Rising Stars on “Data Set”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$50,929,860
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Brian Zavertnik · Palantir Technologies, Inc.$37,240,166
- Jinsy Andrews · Columbia University Health Sciences$21,294,649
- Suma Babu · Massachusetts General Hospital$15,865,175
Research focus
Data SetAdultActive ComparatorAbsorptionAnimal ExperimentationAnticoagulantsAnticoagulationAffectAnimal DataAtrial FibrillationBenchmarkingBiologicalCareerCarrier ProteinsCase StudyClinical RiskCohortComparative SafetyComparison GroupComplex DataCrossover DesignCyp3a4 GeneDatabasesDeep Vein
Grant awards (2)
Interactions of Enzyme-Inducing Antiepileptic Drugs with Direct-Acting Oral Anticoagulants: Risk of Thromboembolic Events$23,314
F31 · FY2024 · NS · contact PI
Interactions of Enzyme-Inducing Antiepileptic Drugs with Direct-Acting Oral Anticoagulants: Risk of Thromboembolic Events$47,694
F31 · FY2023 · NS · contact PI